Skip to main content
Search
Search
Advanced Search
Skip main navigation
Free access
Research Article
17 October 2017

Health technology assessment process of a cardiovascular medical device in four different settings

Authors: Antonio Olry de Labry Lima, Jaime Espín Balbino [email protected], Alexandre Lemgruber, Araceli Caro Martínez, Leticia García-Mochón, Eva Martín Ruiz, and Fernanda LessaAuthor Info & Affiliations
Publication: J. Comp. Eff. Res.
Volume 6, Number 7
https://doi.org/10.2217/cer-2016-0098
PDFFormats

Abstract

Aim: Health technology assessment (HTA) is a tool to help the decision-making process. The aim is to describe methods and processes used in the reimbursement decision making for drug-eluting stents (DES) in four different settings. Methods: DES as a technology under study was selected according to different criteria, all of them agreed by a working group. A survey of key informants was designed. Results: DES was evaluated following well-structured HTA processes. Nonetheless, scope for improvement was observed in relation to the data considered for the final decision, the transparency and inclusiveness of the process as well as in the methods employed. Conclusion: An attempt to describe the HTA processes of a well-known medical device.

Formats available

You can view the full content in the following formats:

View PDFView Full Text

References

1.
Kristensen FB, Mäkelä M, Neikter SA et al. European network for health technology assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for health technology assessment. Int. J. Technol. Assess. Health Care 25(Suppl. 2), 107–116 (2009).
PubMed
Google Scholar
2.
World Health Organization. Health technology assessment of medical devices. WHO Medical Device Technical Series. Geneva, Switzerland (2011). www.who.int/medical_devices/definitions/en/.
Google Scholar
3.
The European Union and Health Services. The impact of the single European market on member states. The European Health Management Association, Amsterdam, the Netherlands (2002). www.amchameu.eu/sites/default/files/amcham_eu_single_market_web.pdf.
Google Scholar
4.
Kramer DB, Xu S, Kesselheim AS. Regulation of medical devices in the United States and European Union. N. Engl. J. Med. 366(9), 848–855 (2012).
PubMed
Google Scholar
5.
Ferguson M. Medical devices are different to pharmaceuticals in the Health Technology Assessment process. J. Comp. Eff. Res. 3(3), 217–219 (2014).
PubMed
Google Scholar
6.
Markiewicz K, van Til JA, IJzerman MJ. Medical devices early assessment methods: systematic literature review. Int. J. Technol. Assess. Health Care 30(2), 137–146 (2014).
PubMed
Google Scholar
7.
Ciani O, Wilcher B, Blankart CR et al. Health technology assessment of medical devices: a survey of non-European union agencies. Int. J. Technol. Assess. Health Care 31(3), 154–165 (2015).
PubMed
Google Scholar
8.
Caro Martínez A, Espín Balbino J, Lemgruber A et al. Adoption of the HPV vaccine: a case study of three emerging countries. J. Comp. Eff. Res. 6(3), 195–204 (2017).
PubMed
Google Scholar
9.
Martín-Ruiz E, Espín Balbino J, Lemgruber A et al. Adoption of trastuzumab for breast cancer in four emerging countries in the use of HTA: a case study. J. Comp. Eff. Res. 5(4), 365–373 (2016).
PubMed
Google Scholar
10.
Drummond MF, Schwartz JS, Jonsson B et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int. J. Technol. Assess. Health Care 24, 244–258 (2008).
PubMed
Google Scholar
11.
Stephens JM, Handke B, Doshi JA. International survey of methods used in health technology assessment (HTA): does practice meet the principles proposed for good research? Comp. Eff. Res. 2, 29–44 (2012).
Google Scholar
12.
Nicod E, Kanavos P. Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: a mixed methods study. Health Pol. 120(1), 35–45 (2016).
PubMed
Google Scholar
13.
Organization for Economic Cooperation and Development. OECD glossary of statistical terms. Organization for Economic Cooperation and Development, Paris, France (2007). https://stats.oecd.org/glossary/.
Google Scholar
14.
Hill RA, Boland A, Dickson R et al. Drug-eluting stents: a systematic review and economic evaluation, 2007. In: NIHR Health Technology Assessment Programme: Executive Summaries. NIHR Journals Library, Southampton, UK (2007).
Google Scholar
15.
Andalusian School of Public Health (EASP). Strengthening and implementing HTA in emerging settings: Central and Eastern Europe and Latin America and the Caribbean. A mapping exercise based on literature review and surveys. EASP/Pan American Health Organization, Granada, Spain (2015).
Google Scholar
17.
Mittmann N, Brown A, Seung SJ et al. Economic evaluation of drug eluting stents [Technology Report No 53]. Canadian Coordinating Office for Health Technology Assessment, ON, Canada (2005).
Google Scholar
18.
Mittmann N, Brown A, Seung SJ et al. Drug eluting stents: an economic evaluation [Technology Overview No 15]. Canadian Coordinating Office for Health Technology Assessment, ON, Canada (2005).
Google Scholar
19.
The National Institute for Health and Care Excellence. Drug-eluting stents for the treatment of coronary artery disease. www.nice.org.uk/guidance/ta152/chapter/About-this-guidance.
Google Scholar
20.
Daniels N, Porteny T, Urrutia J. Expanded HTA: enhancing fairness and legitimacy. Int. J. Health Policy Manag. 5(1), 1–3 (2016).
Google Scholar
21.
Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br. Med. Bull. 96, 5–21 (2010).
PubMed
Google Scholar
22.
Clark S, Weale A. Social values in health priority setting: a conceptual framework. J. Health. Organ. Manag. 26(3), 293–316 (2012).
PubMed
Google Scholar
23.
Advance–HTA website. www.advance-hta.eu.
Google Scholar
24.
Drummond MF, Sculpher MJ, Torrance G, O'Brien J, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd Edition). Oxford University Press, Oxford, England (2005).
Google Scholar
25.
Drummond M, Augustovski F, Kaló Z et al. Challenges faced in transferring economic evaluations to middle income countries. Int. J. Technol. Assess. Health Care 31(6), 442–448 (2015).
PubMed
Google Scholar
26.
Angelis A, Kanavos P. Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment. Pharmacoeconomics 34, 435–446 (2016).
PubMed
Google Scholar
27.
Thokala P, Devlin N, Marsh K et al. Multiple criteria decision analysis for health care decision making--an introduction: Report 1 of the ISPOR MCDA emerging good practices task force. Value Health 19(1), 1–13 (2016).
PubMed
Google Scholar
28.
Martelli N, Hansen P, van den Brink H et al. Combining multi-criteria decision analysis and mini-health technology assessment: a funding decision-support tool for medical devices in a university hospital setting. J. Biomed. Inform. 59, 201–208 (2016).
PubMed
Google Scholar
|